Biomarker: K077-IgE Isocyanate HDI

Overview

K077-IgE Isocyanate HDI measures serum immunoglobulin E (IgE) antibodies specific to hexamethylene diisocyanate (HDI), an industrial isocyanate used in products such as polyurethane coatings and spray paints. HDI exposure can irritate the respiratory tract and cause respiratory sensitization or occupational asthma. A detectable HDI-specific IgE level indicates sensitization and may support an IgE-mediated response, but a negative result does not exclude isocyanate-induced asthma because many cases involve mechanisms other than IgE. The test is therefore used as an adjunct to occupational history, symptom patterns, pulmonary-function testing, serial peak-flow monitoring, and, when clinically appropriate, bronchial challenge testing.

Clinical Use Cases

Supporting the evaluation of suspected HDI-induced occupational asthma.
Identifying sensitization in workers with respiratory symptoms associated with spray painting, coating, automobile refinishing, or other isocyanate exposures.
Helping identify the specific isocyanate associated with symptoms when testing includes HDI, MDI, or TDI.
Providing supportive evidence of an IgE-mediated response in occupational or research investigations.
Assessing sensitization in epidemiologic and occupational-health research.
Complementing, but not replacing, clinical assessment and pulmonary-function testing because sensitivity is limited.

Specimen Types

Venous blood.
Serum, typically separated from clotted whole blood.
Plasma may be accepted by some analytical systems, but specimen requirements are laboratory-specific.

Measurement Methods

Fluorescence enzyme immunoassay, commonly an ImmunoCAP-type assay.
Enzyme-linked immunosorbent assay using HDI-protein conjugates, often HDI-human serum albumin.
Radioallergosorbent testing or related radioimmunoassays, used in earlier clinical research.
Results are commonly reported as allergen-specific IgE concentration in kU/L and/or as an interpretive class.
Assay results depend on the HDI conjugate, antigen preparation, calibration, cutoff, and laboratory method. Specific IgE should be interpreted with clinical findings because cross-reactivity and nonspecific binding can occur.

Test Preparation and Influencing Factors

Fasting is generally not required for serum-specific IgE testing, unless other tests collected at the same time require fasting.
Antihistamines generally do not interfere with blood-based specific IgE testing, unlike skin-prick testing.
Record the date, intensity, and type of occupational or environmental HDI exposure.
When clinically feasible, collect the sample relatively soon after the suspected exposure. One human study found the greatest diagnostic yield when blood was collected within 30 days of the last exposure.
Specific IgE concentrations may decline after exposure ends; one study estimated an approximate six-month antibody half-life.
A positive result indicates sensitization, not necessarily clinical asthma or a current exposure-related illness.
A negative result does not rule out HDI-induced asthma because specific IgE is absent in many affected workers.
Results may be influenced by the antigen used in the assay, cross-reactivity with other isocyanates, total IgE concentration, and nonspecific binding to the carrier protein.
Recent systemic corticosteroid use is not usually a reason to postpone blood-specific IgE testing, but medication history should be documented for clinical interpretation.
Laboratory handling requirements vary. In one human study, serum was processed within eight hours and stored frozen before analysis.